| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |